BridgeMD
New treatment option for HPV
Official title Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers
ClinicalTrials.gov ID: NCT07498075
What this study is testing
- What it's testing
- This study evaluates whether different types of digital health communication can increase parents' intention to vaccinate their daughters against human papillomavirus (HPV) in Nigeria. HPV vaccination is recommended for girls aged 9-14 years and helps prevent cervical cancer, yet vaccination rates remain low.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 27 and older. Healthy volunteers may be eligible.
You may be able to join if
- Parent or primary caregiver of at least one girl aged 9-14 years
- Parent states "no" or "unsure" to question asking if eligible daughter has received any doses of the HPV vaccine
- Provides informed consent to participate
You likely can't join if
- Parent or caregiver of a girl who has already received one or more doses of the HPV vaccine
- Does not meet age eligibility criteria for an eligible daughter
- Fails Attention Checks
The study team makes the final eligibility decision.
Where it's taking place
- Lagos, Nigeria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 27 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lagos, Nigeria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.